Paolo Milani

24PUBLICATIONS
157CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyBioinformatic methods developmentCardiology (incl. cardiovascular diseases)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 22, 2026
Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.

|Sep 14, 2026
A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.

|Dec 07, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.

Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani

|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy.

Laura De Michieli, Giulio Sinigiani, Gianluigi Guida

|Feb 22, 2025
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines.

Eli Muchtar, Martha Grogan, Fabian Aus dem Siepen

|Dec 24, 2024
Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Paolo Milani, Giuseppe Damiano Sanna, Roberta Mussinelli

Pageof 4

Frequent Collaborators

15 joint publications

Giovanni Palladini

12 joint publications

Giampaolo Merlini

6 joint publications

Mario Nuvolone

5 joint publications

Ute Hegenbart